16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
Previously, we discussed the implementation of “shelter in place orders” in the Bay Area that appl...
Read More >
It has been an active last week in the world of the Committee on Foreign Investment in the United St...
Read More >
On February 18, 2020, the Oregon Department of Revenue (“DOR”) issued draft rule OAR 150-317-1220....
Read More >
Marijuana-related employment lawsuits are on the rise as more workers who have been fired or denied ...
Read More >
Seyfarth Synopsis: Governor Murphy has signed multiple Executive Orders which will lessen the COVID-...
Read More >
In the coming months, be on the lookout for an increase in mergers and acquisitions financed by sell...
Read More >